Alerts will be sent to your verified email
Verify Email
SUDARSHAN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sudarshan Pharma Industries Limited is a company engaged in contract manufacturing and supplying generic pharmaceutical formulations and medicines to healthcare institutions, governments, NGOs, and hospitals through outsourcing and import-export services.
Sudarshan Pharma (I) major competitors are Wanbury, Bajaj Healthcare, Bharat Parenterals, Themis Medicare, Kopran, Shree Ganesh Remed., Fermenta Biotech.
Market Cap of Sudarshan Pharma (I) is ₹985 Crs.
While the median market cap of its peers are ₹958 Crs.
Sudarshan Pharma (I) seems to be less financially stable compared to its competitors.
Altman Z score of Sudarshan Pharma (I) is 2.86 and is ranked 8 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Jan May | May Aug | Jul Dec | Jan Mar Sep | |||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
